Eli Lilly to add $4.1B U.S. sales from obesity drug Zepbound Markets November 12, 2023 [ad_1] hapabapa/iStock Editorial by way of Getty Photographs Gross sales from Eli Lilly’s (NYSE:LLY) newly permitted weight reduction treatment, Zepbound,…
